Joanna Davis
Pediatric Hematology-Oncology · Miami, FLNPI 1306873864
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $291,027 of the $411,182 with a category attached, or 70.8%. 15 manufacturers reported payments, led by Sanofi at 45.0% of the total. Reporting peaked in 2019 at $94,531 and has fallen 86.6% since, to $12,671 in 2025. Among pediatric hematology-oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $1293.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$185K
- Genentech USA, Inc.$81K
- Spark Therapeutics, Inc.$57K
- CSL Behring$23K
- Novo Nordisk$20K
- Biomarin Pharmaceutical Inc.$14K
- plus $31K from 9 others
Across 7 payments — averaging $5114.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$19K
- Bayer$17K
What the payments were for
- Consulting fees$74,49118%
- Speaking & faculty fees$291,02771%
- Travel & lodging$41,23510%
- Food & beverage$4,2481%
- Education$1800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 125 | $185,206 |
| Genentech USA, Inc. | 56 | $80,672 |
| Spark Therapeutics, Inc. | 42 | $57,172 |
| CSL Behring | 15 | $22,661 |
| Novo Nordisk | 23 | $19,715 |
| Biomarin Pharmaceutical Inc. | 9 | $14,335 |
| Shire North American Group Inc | 18 | $11,158 |
| Pfizer | 8 | $5,175 |
| Octapharma USA, Inc. | 14 | $5,076 |
| Sanofi-aventis U.S. LLC | 1 | $3,071 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $2,900 |
| Bayer | 1 | $2,375 |
| Bioverativ Therapeutics Inc. | 1 | $1,593 |
| Genentech, Inc. | 1 | $48 |
| Convatec Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$411,182 in reported general payments places this provider in the 95th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Miami
- Guillermo DeanguloMiami$929K
- Fernando Corrales-MedinaMiami$335K
- Rachel KronenfeldMiami$40K
- Maggie FaderMiami$11K
- Ofelia AlvarezMiami$9K
- Julio BarredoMiami$8K
- Jorge Galvez SilvaMiami$7K
- Ossama MaherMiami$6K
- Sasha InclanMiami$5K
- Ziad KhatibMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.